Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. National Institute of Oncology

Source: Site record.

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The National Institute of Oncology Hungary is a leading center for cancer care, research, and education in Hungary. Located in Budapest, it serves as a national reference institution for oncology, providing comprehensive services in cancer diagnosis, treatment, and prevention. The institute offers a wide range of specialized oncology services, including medical oncology, surgical oncology, radiation therapy, and palliative care. It is equipped with modern diagnostic and therapeutic technologies, enabling the management of complex cancer cases. The center is also known for its multidisciplinary approach, ensuring coordinated and personalized treatment plans for patients. In addition to clinical services, the institute plays a significant role in scientific research and innovation, participating in national and international clinical trials. It is also involved in training healthcare professionals and supporting academic development in oncology. By integrating research, education, and…

Source: Trial-derived.
43Total Trials
Source: Trial-derived.
8Recruiting Trials
Source: Trial-derived.
17Active Trials
Source: Trial-derived.
22Completed Trials
Source: Trial-derived.
49Unique Conditions
Source: Trial-derived.
48Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (6)Source: Trial-derived. Quality of Life (3)Source: Trial-derived. Diffuse Large B-Cell Lymphoma (2)Source: Trial-derived. Mastectomy; Lymphedema (2)Source: Trial-derived. Ovarian Cancer (2)Source: Trial-derived. Patient Satisfaction (2)Source: Trial-derived. Squamous Cell Carcinoma of the Oral Cavity (2)Source: Trial-derived. Adult Soft Tissue Sarcoma (1)

Sponsors

Source: Trial-derived. National Institute of Oncology, Hungary (5)Source: Trial-derived. ETOP IBCSG Partners Foundation (4)Source: Trial-derived. Incyte Corporation (4)Source: Trial-derived. AbbVie (3)Source: Trial-derived. Breast International Group (2)Source: Trial-derived. Eli Lilly and Company (2)Source: Trial-derived. European Organisation for Research and Treatment of Cancer - EORTC (2)Source: Trial-derived. Nanobiotix (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan
Source: AI-inferred. PET-CT

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Minimal residual disease (MRD) testing